REATA PHARMACEUTICALS INC short interest in 2019
In 2019, REATA PHARMACEUTICALS INC's disclosed short interest ran from 11.12% of shares outstanding on 15 Oct 2019 to 10.04% on 31 Dec 2019, a change of -1.08 percentage points. The year's high was 11.12% on 15 Oct 2019 and its low 10.04% on 31 Dec 2019, averaging 10.51% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.68 days on 13 Dec 2019. Full history: REATA PHARMACEUTICALS INC.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 11.12% (15 Oct 2019)
- End of year
- 10.04% (31 Dec 2019)
- Change
- -1.08 pp
- High
- 11.12% (15 Oct 2019)
- Low
- 10.04% (31 Dec 2019)
- Average
- 10.51%
- Highest days to cover
- 10.68 (13 Dec 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 11.12% | 4.40 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2019 | 10.47% | 4.55 | |
| 15 Nov 2019 | 10.37% | 3.49 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 10.56% | 6.33 | |
| 13 Dec 2019 | 10.50% | 10.68 | |
| 31 Dec 2019 | 10.04% | 10.05 |
See also: REATA PHARMACEUTICALS INC's full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.